Inova Logo
Banner

704550

QUANTA Lite™ CCP3.1 IgG/IgA ELISA

 

IVD-In Vitro Diagnostic Use CE marked
Technology: ELISA
CLIA Complexity: high

Description:

A semi-quantitative ELISA assay for the detection of anti-CCP3 IgG and IgA antibodies in patient sera, citrated or EDTA plasma. The presence of these antibodies can aid in the diagnosis of rheumatoid arthritis (RA), including RA diagnosed within 2 years of presentation of symptoms.

Antigen: synthetic peptide

Packaging: 1 X 96 wells

Disease State Applications: rheumatoid arthritis

Availability: all regions

MSDS: download in desired language from choices below:

Directional Insert: download in desired language from choices below:


CLSI/NCCLS Formatted Directional Inserts: download in desired language from choices below: